Public Employees Retirement System of Ohio Buys Shares of 34,182 Guardant Health Inc (NASDAQ:GH)

Share on StockTwits

Public Employees Retirement System of Ohio bought a new stake in shares of Guardant Health Inc (NASDAQ:GH) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 34,182 shares of the company’s stock, valued at approximately $2,951,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. NEXT Financial Group Inc boosted its holdings in shares of Guardant Health by 20.0% in the 2nd quarter. NEXT Financial Group Inc now owns 1,200 shares of the company’s stock valued at $104,000 after buying an additional 200 shares in the last quarter. First Trust Advisors LP boosted its holdings in shares of Guardant Health by 0.4% in the 1st quarter. First Trust Advisors LP now owns 71,871 shares of the company’s stock valued at $5,513,000 after buying an additional 264 shares in the last quarter. Advantage Investment Management LLC boosted its holdings in shares of Guardant Health by 200.0% in the 2nd quarter. Advantage Investment Management LLC now owns 450 shares of the company’s stock valued at $39,000 after buying an additional 300 shares in the last quarter. Rhumbline Advisers boosted its holdings in shares of Guardant Health by 1.8% in the 1st quarter. Rhumbline Advisers now owns 20,247 shares of the company’s stock valued at $1,553,000 after buying an additional 367 shares in the last quarter. Finally, Pendal Group Ltd boosted its holdings in shares of Guardant Health by 8.8% in the 2nd quarter. Pendal Group Ltd now owns 4,845 shares of the company’s stock valued at $418,000 after buying an additional 390 shares in the last quarter. 81.40% of the stock is currently owned by institutional investors and hedge funds.

GH stock traded down $0.64 during trading on Monday, reaching $76.86. The company had a trading volume of 311,869 shares, compared to its average volume of 1,085,683. The firm has a 50-day simple moving average of $93.18 and a 200-day simple moving average of $82.08. The company has a market cap of $7.11 billion and a price-to-earnings ratio of -27.45. Guardant Health Inc has a twelve month low of $27.04 and a twelve month high of $112.21.

Guardant Health (NASDAQ:GH) last released its earnings results on Tuesday, August 6th. The company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.34) by $0.21. The company had revenue of $53.98 million during the quarter, compared to analysts’ expectations of $35.97 million. Guardant Health had a negative net margin of 60.08% and a negative return on equity of 22.93%. Guardant Health’s revenue for the quarter was up 178.5% on a year-over-year basis. During the same period last year, the business earned ($1.75) EPS. As a group, analysts expect that Guardant Health Inc will post -1.27 earnings per share for the current year.

In other Guardant Health news, major shareholder Vision Fund (Aiv M1) Softbank sold 4,900,000 shares of Guardant Health stock in a transaction that occurred on Wednesday, September 11th. The shares were sold at an average price of $77.00, for a total transaction of $377,300,000.00. Also, insider Richard B. Lanman sold 63,075 shares of Guardant Health stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $105.25, for a total transaction of $6,638,643.75. The disclosure for this sale can be found here. Insiders sold a total of 5,904,867 shares of company stock valued at $477,783,206 over the last quarter. 13.00% of the stock is owned by company insiders.

A number of analysts have recently weighed in on GH shares. Cowen set a $110.00 price target on shares of Guardant Health and gave the company a “buy” rating in a report on Wednesday, August 7th. Zacks Investment Research cut shares of Guardant Health from a “strong-buy” rating to a “hold” rating in a report on Saturday, August 10th. Canaccord Genuity restated a “buy” rating and issued a $125.00 price target (up from $96.00) on shares of Guardant Health in a report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. raised their price target on shares of Guardant Health from $90.00 to $135.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. Guardant Health presently has an average rating of “Buy” and a consensus target price of $111.80.

Guardant Health Profile

Guardant Health, Inc, a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications.

See Also: What does a neutral rating on stocks mean?

Want to see what other hedge funds are holding GH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardant Health Inc (NASDAQ:GH).

Institutional Ownership by Quarter for Guardant Health (NASDAQ:GH)

Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Nuveen Asset Management LLC Makes New Investment in J & J Snack Foods Corp
Nuveen Asset Management LLC Makes New Investment in J & J Snack Foods Corp
Nuveen Asset Management LLC Invests $10.74 Million in The Providence Service Co.
Nuveen Asset Management LLC Invests $10.74 Million in The Providence Service Co.
Nuveen Asset Management LLC Buys New Shares in MRC Global Inc
Nuveen Asset Management LLC Buys New Shares in MRC Global Inc
Nuveen Asset Management LLC Purchases 523,047 Shares of Ferro Co.
Nuveen Asset Management LLC Purchases 523,047 Shares of Ferro Co.
2,205 Shares in Lowe’s Companies, Inc.  Acquired by Manning & Napier Group LLC
2,205 Shares in Lowe’s Companies, Inc. Acquired by Manning & Napier Group LLC
Manning & Napier Group LLC Sells 141,783 Shares of SPDR Nuveen Barclays Short Term Municipal Bond ETF
Manning & Napier Group LLC Sells 141,783 Shares of SPDR Nuveen Barclays Short Term Municipal Bond ETF


© 2006-2019 Ticker Report